Arcellx, Inc. (ACLX)

66.04 +1.17 (+1.80%) USD  |  NASDAQ  |  Jan 13, 12:40
More

Arcellx EPS Diluted from Discontinued Operations (Quarterly)

EPS Diluted from Discontinued Operations (Quarterly) Chart

View EPS Diluted from Discontinued Operations (Quarterly) for ACLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted from Discontinued Operations (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted from Discontinued Operations (Quarterly) Range, Past 5 Years

View EPS Diluted from Discontinued Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Discontinued Operations (Quarterly) Benchmarks

View EPS Diluted from Discontinued Operations (Quarterly) Benchmarks
Start Trial
Gilead Sciences, Inc. --
Johnson & Johnson Upgrade
Amicus Therapeutics, Inc. --
Relmada Therapeutics, Inc. --
Invivyd, Inc. --